REPRIEVE Study

Protecting One's Heart The REPRIEVE study aims to prevent cardiovascular disease by Chael Needle As people are living longer with HIV, researchers have been increasingly attending to...

Vpu Inhibitor Candidate

BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....

Long-Term Survivors: More Than Surviving

More Than Surviving A new report calls for aging well with HIV by Chael Needle More than half of the 1.2 million people living with HIV in...

HIV Therapeutic Vaccine Advances

Treatment Horizons Another Kind of Morning HIV therapeutic vaccines try to come of age by Mariel Selbovitz, MPJ, and David Miller Despite over three decades of research on...

Curing Hep B

C2B The success in curing hep C fuels race to cure B by Larry Buhl In 2013, a revolution happened: A drug regimen was developed that could...

Talking “Cure”

Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....

Meridians of Health

Acupuncture is an Eastern healing modality that is said to have originated some 2,500 years ago. It falls under the umbrella of Traditional Chinese...

Survivor’s Fatigue

What’s Your Damage?” was the name of the arts panel that kicked off the opening night of ACT UP/San Francisco’s reunion gathering commemorating the...

Cannabinoids as Treatment

Wellness Watch by Jeannie Wraight CB Breaker Cannabinoids may be effective in treating HIV, not just relieving symptoms The legalization of medical marijuana has been a...

Countdown to a Cure

by Jeannie Wraight As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...